Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Valethamate Bromide Versus Hyoscine Butyl Bromide in Reducing Labour Duration Among Primigravida: A Randomised Controlled Trial.

NCT07474350 is registered in ClinicalTrials.gov with Federal Teaching Hospital Abakaliki as lead sponsor.

NCT NCT07474350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07474350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Valethamate Bromide Versus Hyoscine Butyl Bromide in Reducing Labour Duration Among Primigravida: A Randomised Controlled Trial.
Lead sponsor
Federal Teaching Hospital Abakaliki
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2023
Completion date
January 23, 2024
Enrollment
165 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

labour duration, primigravida